SynthesisBMC cardiovascular disorders2025
Reprogramming heart failure: physiological orchestration and mechanistic decoding of exercise benefits.
Synthesis in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure (HF) is a complex clinical syndrome caused by a variety of reasons leading to structural or functional damage to the heart and a decline in the heart's pumping ability, and it is the endpoint of various cardiovascular diseases, which is based on the decompensation for myocardial cell function. In the pathophysiology of HF, pathological structures, abnormal neurohumoral, cellular reprogramming, and molecular mechanisms are activated and form a network to sustain physiological phenomena. These coordinated biochemical processes promote increased sympathetic activity and circulatory redistribution and are also accompanied by the onset of distinct, parallel clinical symptoms. Invasive and/or medicamentous procedures for HF endeavour to maintain and limit these compensatory mechanisms to the physiological range, and more strides are still needed to ameliorate patients' quality of life. Non-invasive therapeutic options (physical exercise) offer new entry points for the management of HF. Continuously optimized exercise protocols and therapeutic targets are indispensable for a deeper understanding of the fine processes by which exercise modulates HF. This review will focus on how different exercises modulate myocardial mitochondrial bioenergetics, angiogenesis, cardiogenic dementia, and microRNAs associated with HF in order to comprehensively consolidate a compact overview of basic mechanisms and of the novel unfolding, and to encourage further research in this field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.